Podcast

The Power of Patience for Long-Term Value

Catch the Full Episode

On the third episode of The End Podcast, our guest is Markus Feuerecker, professional investor at YZL Capital and passionate for health tech, who has supported more than 20 European founders so far. In conversations with CEO Pedro Coelho, we discover his professional journey, investment philosophy and operational approach.

They discuss: 

 • Why empathy and patience matter more than constant investor activity

 • The kind of founder he backs: passionate, ambitious, sometimes seen as “a bit lunatic”

 • How investors should act as calm, rational voices in the toughest boardroom moments

 • Why being wrong is inevitable — but never for reasons you failed to anticipate

This conversation explores the human side of venture: conviction, trust, and the partnerships that shape healthcare innovation.

On the third episode of The End Podcast, our guest is Markus Feuerecker, professional investor at YZL Capital and passionate for health tech, who has supported more than 20 European founders so far. In conversations with CEO Pedro Coelho, we discover his professional journey, investment philosophy and operational approach.

They discuss: 

 • Why empathy and patience matter more than constant investor activity

 • The kind of founder he backs: passionate, ambitious, sometimes seen as “a bit lunatic”

 • How investors should act as calm, rational voices in the toughest boardroom moments

 • Why being wrong is inevitable — but never for reasons you failed to anticipate

This conversation explores the human side of venture: conviction, trust, and the partnerships that shape healthcare innovation.

Want to become a podcast guest?

Reach out

Ready to accelerate your
next clinical trial?

Reach out

Ready to accelerate your
next clinical trial?

Reach out

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

@2026 Biorce | All Rights Reserved

Partners with

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

@2026 Biorce | All Rights Reserved

Partners with

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Partners with

@2026 Biorce | All Rights Reserved